In Pharma Sustainability, AstraZeneca, Johnson & Johnson Rate High
On a scale of 1 to 100, AstraZeneca and Johnson & Johnson are the only pharmaceutical companies to rate above 70 in a recent survey of sustainability practices in the sector.
Other firms scoring highly are Baxter (66) and GlaxoSmithKline, Pfizer and Schering-Plough, all three of which scored 60.
Climate Counts evaluates firms’ commitments in four areas:
- whether they have measured their carbon footprint
- if they reduced their impact on global warming
- if they have supported or blocked climate legislation or policy
- to what level they have publicly disclosed their climate actions
AstraZeneca scored highly in all sectors except for policy, in which it scored a zero out of ten.
Johnson & Johnson scored highly in all sectors except for measuring its own carbon footprint, an area in which it scored 12 out of 22.
Energy Manager News
- Put Safety First in LED Installations
- Microsoft: Data Centers to Use 50% Renewables by 2018
- Solar Installation Dedicated in Brooklyn
- Duke Energy SC Customers Have Reaped $5M in Solar Rebates Since Last October
- BidEnergy Launches Its ‘Source-to-Pay’ Process for Energy in U.S. Market
- Garden State Residential, Commercial Customers Will Pay Less for Gas This Winter
- Better Buildings, Better Plants: 12 Success Stories
- CA Governor Signs Bill Clarifying PACE Disclosures